LQAI · Exit · 1d
weight 0.200% → 0 (exited)·stock down 1.9% in the 30 days before
Aug 6·entry $57.26·now $59.45
+3.82%
since Aug 6
RPRX
DefensiveROYALTY PHARMA PLC
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases.
Close · 3M
+28.26%
Held by 0 AI ETFs
None of the tracked AI ETFs currently hold this name.
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals3
Win rate100% (3/3)
Avg buy return+5.56%
LQAI · Weight increase · 2d
weight 0.190% → 0.210% (+0.020 pp)·stock up 6.1% in the 30 days before
Jul 17·entry $58.18·now $59.45Drifting
+2.18%
since Jul 17
LQAI · New entry · 1d
weight 0 → 0.200% (new)·stock up 7.1% in the 30 days before
Jul 7·entry $57.80·now $59.45Drifting
+2.85%
since Jul 7
LQAI · Exit · 1d
weight 0.860% → 0 (exited)·stock up 9.5% in the 30 days before
Jun 9·entry $55.63·now $59.45
+6.87%
since Jun 9
LQAI · Weight decrease · 2d
weight 0.840% → 0.810% (-0.030 pp)·stock up 9.2% in the 30 days before
Jun 2·entry $54.01·now $59.45
+10.07%
since Jun 2
LQAI · Weight increase · 2d
weight 0.480% → 0.840% (+0.360 pp)·stock up 9.1% in the 30 days before
May 13·entry $53.25·now $59.45Chased
+11.64%
since May 13
LQAI · Sudden change · 1d
weight 0.480% → 0.820% (+0.340 pp)·stock up 6.8% in the 30 days before
May 12·entry $51.70·now $59.45
+14.99%
since May 12
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.